Altered pulmonary vasoreactivity in the chronically hypoxic lung

Physiological Research

Volumn 49, Issue 5, 2000, Pages 549-560

  Shimoda, Larissa A ^a,b   Sham, J S K ^a   Sylvester, J T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

Angiotensin II; Contraction; Endothelin 1; Membrane potential; Nitric oxide; Pulmonary hypertension

Indexed keywords

ANGIOTENSIN; CARBON MONOXIDE; ENDOTHELIN 1; NITRIC OXIDE; PROSTACYCLIN DERIVATIVE;

CONFERENCE PAPER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LUNG DISEASE; LUNG PARENCHYMA; MEMBRANE DEPOLARIZATION; POTASSIUM TRANSPORT; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; ANOXIA; CHRONIC DISEASE; HUMANS; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; PULMONARY CIRCULATION; VASOCONSTRICTION; VASOMOTOR SYSTEM;

EID: 0033709982     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (119)

1. Endothelin-1-induced phcsphorylation of the 20-kDa myosin light chain and caldesmon in porcine coronary smooth muscle
2. Myosin light chain and caldesmon phosphorylation in arterial muscle stimulated with endothelin-1
3. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia
4. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension
5. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor
6. Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia
7. Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension
8. + currents in arterial myocytes
9. Mechanism of action of endothelin-1 in the canine pulmonary circulation
10. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated
11. BQ123, an ET(A) receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation
12. BQ-123, an ET(A)-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats
13. Effects of verapamil on pulmonary hemodynamics during hypoxemia, at rest and during exercise in patients with chronic obstructive pulmonary disease
14. Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rats exposed to chronic hypoxia: Effects of in vivo and in vitro supplementation with L-arginine
15. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
16. 2+ in fetal pulmonary artery smooth muscle cells
17. 2+ influx in fetal pulmonary artery smooth muscle cells
18. Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat
19. Hemodynamic effects of basal and stimulated release of endogenous nitric oxide in isolated human lungs
20. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled
21. Heterogeneity in the proliferative response of bovine pulmonary artery smooth muscle cells to mitogens and hypoxia: Importance of protein kinase C
22. ET(A)-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat
23. Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to L-arginine deficiency
24. Pulmonary vascular reactivity to endothelin-1 in normal and chronically hypertensive rats
25. L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats
26. Dilator effect of endothelins in pulmonary circulation: Changes associated with chronic hypoxia
27. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats
28. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat
29. Site of action of endogenous nitric oxide on pulmonary vasculature in rats
30. Circulating endothelin-1 concentrations in patients with chronic hypoxia
31. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lungs
32. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo
33. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities
34. Effects of N(ω)-nitro-L-arginine on total and segmental vascular resistances in developing lamb lungs
35. 2+ channel in vascular smooth muscle
36. 2+-oscillations in vascular myocytes from the rat pulmonary artery
37. Impairment of hypoxic pulmonary artery remodeling by heparin in mice
38. 2+-dependent action potentials in small pulmonary arteries of cat
39. Angiotensin II up-regulates the expression of type A endothelin receptor in human vascular smooth muscle cells
40. 2+-independent contraction in vascular smooth muscle
41. Mechanism of endothelin-1-induced pulmonary vasoconstriction
42. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats
43. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor 1 binding site on the antisense strand
44. Cellular mechanisms and role of endothelin-1-induced calcium oscillations in pulmonary arterial myocytes
45. Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia
46. Acute and long-term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease
47. NO: COPD and beyond
48. Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells
49. Effect of endothelin on angiotensin converting enzyme activity in cultured pulmonary artery endothelial cells
50. Lung angiotensin converting enzyme activity in chronically hypoxic rats
51. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia
52. Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature
53. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats
54. 2+ channels on stimulated calcium influx and on proliferative activity of human coronary smooth muscle cells
55. Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung
56. Increased endothelin receptor gene expression in hypoxic rat lung
57. Endothelin produces pulmonary vasoconstriction and systemic vasodilation
58. Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer
59. Effects of pulmonary hypertension on vasoconstrictor responses to endothelin-1 and sarafotoxin S6C on inherent tone in rat pulmonary arteries
60. Effect of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale
61. Hypoxia-induced activation in small isolated pulmonary arteries
62. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: Effect of chronic hypoxia in the rat
63. Inhibition of hypoxic pulmonary vasoconstriction by calcium channel antagonists in isolated rat lungs
64. Lungs from chronically hypoxic rats have decreased pressor response to acute hypoxia
65. Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle
66. The sequence of cellular and hemodynamic changes of chronic pulmonary hypertension induced by hypoxia and other stimuli
67. Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats
68. Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease
69. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide
70. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP
71. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension
72. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension
73. 1 receptor
74. The effect of N(ω)-nitro-L-arginine methylester on hypoxic vasoconstriction in the neonatal pig lung
75. Captopril inhibits proliferation of human lung fibroblasts in culture: A potential antifibrotic mechanism
76. 2+ sensitivity in α-toxin-permeablized rabbit mesenteric artery
77. N(ω)-nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs
78. Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling
79. NIP-121 is more effective than nifedipine in acutely reversing chronic hypoxic pulmonary hypertension
80. Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats
81. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat
82. Transpulmonary angiotensin II formation and pulmonary haemodynamics in stable hypoxic lung disease: The effect of captopril
83. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts
84. + channels: Regulation in human pulmonary vascular smooth muscle cells
85. ET-1 modulates K(Ca)-channel activity and arterial tension in normoxic and hypoxic human pulmonary vasculature
86. Effects of chronic hypoxia on pulmonary vascular responses to biogenic amines
87. Amiloride analogs inhibit chronic hypoxic pulmonary hypertension
88. Rat pulmonary circulation after chronic hypoxia: Hemodynamic and structural features
89. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension
90. + channel-mediated relaxation
91. Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery
92. Chronic inhaled nitric oxide: Effects on pulmonary vascular endothelial function and pathology in rats
93. Effect of chronic hypoxia on endothelium-dependent relaxation and cGMP content in rat pulmonary artery
94. Attenuation of chronic hypoxic pulmonary hypertension in rats by cyclooxygenase products and by nitric oxide
95. Endothelin-1, delayed rectifier K channels, and pulmonary arterial muscle
96. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung
97. Flow-induced responses in cat pulmonary arteries
98. +) current in rat intrapulmonary arterial smooth muscle cells
99. + currents in pulmonary arterial myocytes
100. 2+-dependence of endothelin-1 (ET-1)-induced contraction in rat intrapulmonary arterial smooth muscle
101. 2+ by endothelin- 1 in rat intrapulmonary arterial smooth muscle cells
102. Acute haemodynamic effects of nifedipine at rest and during maximal exercise in patients with chronic cor pulmonale
103. + current in rat pulmonary artery muscle cells
104. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3
105. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
106. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: Role of a wortmannin-sensitive signaling pathway
107. Membrane properties of smooth muscle cells in pulmonary hypertensive rats
108. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension
109. Pulmonary pressor response after prostaglandin synthesis inhibition in conscious dogs
110. + channel alpha subunits in pulmonary arterial smooth muscle cells
111. Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension
112. Prostaglandin synthetase inhibitors do not decrease hypoxic pulmonary vasoconstriction
113. Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation
114. Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat
115. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice
116. 2+](i) in pulmonary arterial myocytes
117. + channels
118. Nitric oxide inhibits serotonin-induced calcium release in pulmonary artery smooth muscle cells
119. BQI23, an ET(A) receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells